Physician profile
Michael Weiss
NPI 1265421184
$33,533.96
in general payments reported to CMS, 2019-2025
14 companies · $3,442 in 2025
The $3,442 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,996 · 2020: $2,862 · 2021: $5,133 · 2022: $6,769 · 2023: $10K · 2024: $39.81 · 2025: $3,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $12K · Travel and Lodging: $1,189 · Consulting Fee: $250 · Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $12,128.99 |
| Travel and Lodging | $1,188.92 |
| Consulting Fee | $250.00 |
| Food and Beverage | $207.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $31,661.46 | 2019-2025 | Spira |
| Wenzel Spine, INC. | $542.65 | 2022 | |
| Biotissue Holdings INC. | $383.95 | 2025 | |
| Spineology INC. | $209.73 | 2019 | |
| Surgalign Spine Technologies, INC. | $194.74 | 2019-2021 | |
| Camber Spine Technologies LLC | $168.48 | 2019-2023 | |
| Captiva Spine INC | $111.02 | 2022 | |
| Allergan, INC. | $94.13 | 2019 | |
| Centinel Spine, LLC | $54.17 | 2022-2024 | Prodisc C Vivo |
| Ossdsign USA Incorporated | $39.46 | 2023 | |
| Corelink, LLC | $26.22 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $21.26 | 2020 | |
| Boston Scientific Corporation | $16.30 | 2019 | |
| Electronic Waveform Lab, INC. | $10.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.